GlassScriptPhysician profile
Kay H Chandler
NPI 1922075746
$4,648.69
in general payments reported to CMS, 2019-2025
31 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,847 · 2020: $129 · 2021: $696 · 2022: $499 · 2023: $735 · 2024: $494 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,478.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $1,600.69 | 2019 | |
| Abbvie INC. | $530.56 | 2019-2024 | Lo Loestrin Fe |
| Astellas Pharma US INC | $417.91 | 2019-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $310.64 | 2019-2025 | |
| Aspira Women'S Health INC | $181.08 | 2021 | |
| Exeltis, USA INC. | $163.83 | 2020-2023 | Slynd |
| Mayne Pharma Commercial LLC | $144.99 | 2023-2025 | |
| Therapeuticsmd, INC. | $130.53 | 2019-2022 | |
| Organon LLC | $130.21 | 2021-2024 | Nexplanon |
| Davol INC. | $127.44 | 2022-2023 | Arista Ah Flexitip |
| Allergan, INC. | $122.40 | 2019-2021 | |
| Medtronic, INC. | $117.66 | 2023 | Signia |
| Pfizer INC. | $104.92 | 2022-2024 | |
| Shield Therapeutics INC | $97.46 | 2023-2025 | Accrufer |
| Merck Sharp & Dohme LLC | $55.91 | 2021-2023 | Gardasil 9 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $44.06 | 2024-2025 | Zurzuvae |
| Avion Pharmaceuticals | $43.35 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $42.85 | 2021-2022 | |
| Hologic Sales and Service, LLC | $42.05 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Ethicon US, LLC | $38.28 | 2021 | |
| Evofem Biosciences, INC. | $29.24 | 2021 | |
| Scynexis, INC. | $27.18 | 2022 | |
| Sumitomo Pharma America, INC. | $23.56 | 2023 | Myfembree |
| Becton, Dickinson and Company | $20.04 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.36 | 2023 | Exparel |
| Meditrina | $16.09 | 2021 | |
| Lupin INC. | $15.62 | 2020 | |
| Acella Pharmaceuticals, LLC | $14.93 | 2023 | NP Thyroid 60 |
| Smith+Nephew, INC. | $14.44 | 2022 | |
| Myovant Sciences INC. | $12.17 | 2022 | |
| Covidien LP | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kay Chandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.